vs
Side-by-side financial comparison of LifeMD, Inc. (LFMD) and STEM, INC. (STEM). Click either name above to swap in a different company.
LifeMD, Inc. is the larger business by last-quarter revenue ($60.2M vs $47.1M, roughly 1.3× STEM, INC.). LifeMD, Inc. runs the higher net margin — -6.3% vs -33.9%, a 27.6% gap on every dollar of revenue. On growth, LifeMD, Inc. posted the faster year-over-year revenue change (13.0% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 24.8%).
SBI Life Insurance Company Limited is an Indian life insurance company. It was started as a joint venture between State Bank of India (SBI) and French financial institution BNP Paribas Cardif.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
LFMD vs STEM — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $60.2M | $47.1M |
| Net Profit | $-3.8M | $-16.0M |
| Gross Margin | 87.7% | 48.9% |
| Operating Margin | -3.3% | -17.7% |
| Net Margin | -6.3% | -33.9% |
| Revenue YoY | 13.0% | -15.6% |
| Net Profit YoY | 18.3% | 68.8% |
| EPS (diluted) | — | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $47.1M | ||
| Q3 25 | $60.2M | $38.2M | ||
| Q2 25 | $62.7M | $38.4M | ||
| Q1 25 | $64.1M | $32.5M | ||
| Q4 24 | — | $55.8M | ||
| Q3 24 | $53.3M | $29.3M | ||
| Q2 24 | $50.7M | $34.0M | ||
| Q1 24 | $44.1M | $25.5M |
| Q4 25 | — | $-16.0M | ||
| Q3 25 | $-3.8M | $-23.8M | ||
| Q2 25 | $-1.6M | $202.5M | ||
| Q1 25 | $-183.8K | $-25.0M | ||
| Q4 24 | — | $-51.1M | ||
| Q3 24 | $-4.7M | $-148.3M | ||
| Q2 24 | $-6.9M | $-582.3M | ||
| Q1 24 | $-6.8M | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | 87.7% | 35.5% | ||
| Q2 25 | 88.1% | 33.4% | ||
| Q1 25 | 86.5% | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | 90.6% | 21.2% | ||
| Q2 24 | 90.1% | 27.6% | ||
| Q1 24 | 89.6% | -95.0% |
| Q4 25 | — | -17.7% | ||
| Q3 25 | -3.3% | -33.6% | ||
| Q2 25 | -0.7% | -34.8% | ||
| Q1 25 | 1.5% | -65.0% | ||
| Q4 24 | — | -84.4% | ||
| Q3 24 | -7.5% | -493.2% | ||
| Q2 24 | -12.4% | -1705.5% | ||
| Q1 24 | -14.0% | -267.0% |
| Q4 25 | — | -33.9% | ||
| Q3 25 | -6.3% | -62.2% | ||
| Q2 25 | -2.6% | 527.8% | ||
| Q1 25 | -0.3% | -76.9% | ||
| Q4 24 | — | -91.6% | ||
| Q3 24 | -8.7% | -506.3% | ||
| Q2 24 | -13.6% | -1712.6% | ||
| Q1 24 | -15.3% | -283.9% |
| Q4 25 | — | $-4.40 | ||
| Q3 25 | — | $-2.84 | ||
| Q2 25 | $-0.05 | $-1.79 | ||
| Q1 25 | $-0.02 | $-0.15 | ||
| Q4 24 | — | $-15.29 | ||
| Q3 24 | $-0.13 | $-18.24 | ||
| Q2 24 | — | $-71.81 | ||
| Q1 24 | — | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3M | $-249.4M |
| Total Assets | $66.0M | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $48.9M | ||
| Q3 25 | — | $43.1M | ||
| Q2 25 | $36.2M | $40.8M | ||
| Q1 25 | $34.4M | $58.6M | ||
| Q4 24 | — | $56.3M | ||
| Q3 24 | $37.6M | $75.4M | ||
| Q2 24 | $35.7M | $89.6M | ||
| Q1 24 | $35.1M | $112.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $15.9M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $-249.4M | ||
| Q3 25 | $1.3M | $-235.7M | ||
| Q2 25 | $-1.8M | $-214.1M | ||
| Q1 25 | $-2.3M | $-417.5M | ||
| Q4 24 | — | $-398.4M | ||
| Q3 24 | $-7.7M | $-344.1M | ||
| Q2 24 | $-4.2M | $-203.2M | ||
| Q1 24 | $-845.3K | $371.6M |
| Q4 25 | — | $308.9M | ||
| Q3 25 | $66.0M | $362.6M | ||
| Q2 25 | $73.6M | $379.2M | ||
| Q1 25 | $73.6M | $405.1M | ||
| Q4 24 | — | $437.4M | ||
| Q3 24 | $72.6M | $537.8M | ||
| Q2 24 | $63.8M | $691.5M | ||
| Q1 24 | $61.5M | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-147.1K | $8.2M |
| Free Cash FlowOCF − Capex | $-944.4K | — |
| FCF MarginFCF / Revenue | -1.6% | — |
| Capex IntensityCapex / Revenue | 1.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $16.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.2M | ||
| Q3 25 | $-147.1K | $11.4M | ||
| Q2 25 | $8.6M | $-21.3M | ||
| Q1 25 | $3.1M | $8.5M | ||
| Q4 24 | — | $-14.7M | ||
| Q3 24 | $6.7M | $-9.4M | ||
| Q2 24 | $4.5M | $-11.9M | ||
| Q1 24 | $5.2M | $-621.0K |
| Q4 25 | — | — | ||
| Q3 25 | $-944.4K | — | ||
| Q2 25 | $7.8M | — | ||
| Q1 25 | $2.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $3.9M | — | ||
| Q1 24 | $5.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | -1.6% | — | ||
| Q2 25 | 12.5% | — | ||
| Q1 25 | 4.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 11.7% | — | ||
| Q2 24 | 7.7% | — | ||
| Q1 24 | 11.4% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 0.4% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFMD
| Telehealth Subscription Revenue | $27.3M | 45% |
| Telehealth | $20.0M | 33% |
| Work Simpli Revenue | $12.9M | 21% |
| Product And Services | $2.5M | 4% |
STEM
Segment breakdown not available.
